U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07889622) titled 'Effects and Feasibility of a HABIT-ILE and a Home Program on the Bimanual Performance of Ch... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07888504) titled 'Low-Dose Spironolactone in Hemodialysis Patients With Resistant Hypertension' on Oct. 14. ... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07889349) titled 'A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in ... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07889947) titled 'Combining Gene Editing and iPS to Study and Treat Monogenic Autoinflammatory Diseases' on O... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07888088) titled 'Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults' ... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07888530) titled 'Non-Interventional Study of Ranicabtagene Autoleucel Injection for Relapsed/Refractory B-ce... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890103) titled 'Learning Curve of Tri-lobar HoLEP Versus En-bloc HoLEP' on Oct. 13. Brief Summary: Several... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890610) titled 'Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest' on Oct. 16. Brief Summ... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07887880) titled 'A Novel Multimodal Approach to Promote Motor Recovery and Plasticity After Stroke' on July ... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890636) titled 'Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC' on Oct. 16. Brief Summary... Read More